236 related articles for article (PubMed ID: 24963123)
1. Botulinum toxin and blink rate in patients with blepharospasm and increased blinking.
Ferrazzano G; Conte A; Fabbrini G; Bologna M; Macerollo A; Defazio G; Hallett M; Berardelli A
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):336-40. PubMed ID: 24963123
[TBL] [Abstract][Full Text] [Related]
2. Blinking Parameters Do Not Normalize After Botulinum Toxin Therapy in Blepharospasm and Hemifacial Spasm Patients.
Gameiro GR; Osaki MH; Yabumoto C; Osaki T; Garcia DM; Belfort R; Cruz AAV; Osaki TH
J Neuroophthalmol; 2023 Dec; 43(4):563-568. PubMed ID: 37307066
[TBL] [Abstract][Full Text] [Related]
3. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
[TBL] [Abstract][Full Text] [Related]
4. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
[TBL] [Abstract][Full Text] [Related]
5. Is increased blinking a form of blepharospasm?
Conte A; Defazio G; Ferrazzano G; Hallett M; Macerollo A; Fabbrini G; Berardelli A
Neurology; 2013 Jun; 80(24):2236-41. PubMed ID: 23751916
[TBL] [Abstract][Full Text] [Related]
6. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
Bastola P; Chaudhary M; Agrawal JP; Shah DN
Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
[TBL] [Abstract][Full Text] [Related]
7. Writing, reading, and speaking in blepharospasm.
Ferrazzano G; Conte A; Belvisi D; Fabbrini A; Baione V; Berardelli A; Fabbrini G
J Neurol; 2019 May; 266(5):1136-1140. PubMed ID: 30783748
[TBL] [Abstract][Full Text] [Related]
8. The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery.
Trinchillo A; Cuomo N; Habetswallner F; Esposito M
Parkinsonism Relat Disord; 2024 Feb; 119():105958. PubMed ID: 38118281
[TBL] [Abstract][Full Text] [Related]
9. Blink index as a response predictor of blepharospasm to botulinum neurotoxin-A treatment.
Jang J; Lew H
Brain Behav; 2021 Nov; 11(11):e2374. PubMed ID: 34555267
[TBL] [Abstract][Full Text] [Related]
10. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
Park DI; Shin HM; Lee SY; Lew H
Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
[TBL] [Abstract][Full Text] [Related]
11. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
Lolekha P; Choolam A; Kulkantrakorn K
Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
[TBL] [Abstract][Full Text] [Related]
12. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study.
Girlanda P; Quartarone A; Sinicropi S; Nicolosi C; Messina C
Mov Disord; 1996 Jan; 11(1):27-31. PubMed ID: 8771064
[TBL] [Abstract][Full Text] [Related]
13. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
[TBL] [Abstract][Full Text] [Related]
14. An objective tool to measure the effect of botulinum toxin in blepharospasm and hemifacial spasm.
Osaki MH; Osaki TH; Garcia DM; Osaki T; Gameiro G; Belfort R; Cruz AAV
Eur J Neurol; 2020 Aug; 27(8):1487-1492. PubMed ID: 32294304
[TBL] [Abstract][Full Text] [Related]
15. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection.
Casse G; Adenis JP; Sauvage JP; Robert PY
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129
[TBL] [Abstract][Full Text] [Related]
16. Disease progression in blepharospasm: a 5-year longitudinal study.
Ferrazzano G; Conte A; Gigante A; Defazio G; Berardelli A; Fabbrini G
Eur J Neurol; 2019 Feb; 26(2):268-273. PubMed ID: 30308706
[TBL] [Abstract][Full Text] [Related]
17. Long-term adherence and response to botulinum toxin in different indications.
Lee JI; Jansen A; Samadzadeh S; Kahlen U; Moll M; Ringelstein M; Soncin G; Bigalke H; Aktas O; Moldovan AS; Waskoenig J; Jander S; Gliem M; Schnitzler A; Hartung HP; Hefter H; Albrecht P
Ann Clin Transl Neurol; 2021 Jan; 8(1):15-28. PubMed ID: 33259153
[TBL] [Abstract][Full Text] [Related]
18. Blepharospasm with elevated anti-acetylcholine receptor antibody titer.
Tang M; Li W; Liu P; He F; Ji F; Meng F
Arq Neuropsiquiatr; 2018 Aug; 76(8):522-526. PubMed ID: 30231125
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.
Sung Y; Nam SM; Lew H
Korean J Ophthalmol; 2015 Apr; 29(2):115-20. PubMed ID: 25829828
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
